GlassScriptPhysician profile
Todd S Newberger
NPI 1639182355
$1,996.11
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $752 · 2021: $546.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $473.38 | 2019-2021 | |
| Pfizer INC. | $271.75 | 2019-2021 | |
| Bausch Health US, LLC | $204.95 | 2019-2021 | |
| Amarin Pharma, INC. | $167.93 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $151.89 | 2019-2021 | |
| Allergan, INC. | $147.84 | 2019-2020 | |
| Novo Nordisk INC | $94.44 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $85.66 | 2019-2020 | |
| Abbvie INC. | $64.30 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.32 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $49.64 | 2019-2021 | |
| Glaxosmithkline, LLC. | $46.20 | 2020 | |
| Sanofi Pasteur INC. | $42.50 | 2019-2020 | |
| Lilly USA, LLC | $28.91 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $19.83 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $18.37 | 2020 | |
| Melinta Therapeutics, LLC | $15.84 | 2019 | |
| Bioventus LLC | $15.25 | 2019 | |
| Qol Medical, LLC | $14.46 | 2019 | |
| Philips North America LLC | $13.54 | 2019 | |
| Genentech USA, INC. | $12.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Newberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.